Product NDC: | 0597-0013 |
Proprietary Name: | Combivent |
Non Proprietary Name: | ipratropium bromide and albuterol sulfate |
Active Ingredient(s): | 103; 18 ug/1; ug/1 & nbsp; ipratropium bromide and albuterol sulfate |
Administration Route(s): | RESPIRATORY (INHALATION) |
Dosage Form(s): | AEROSOL, METERED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0597-0013 |
Labeler Name: | Boehringer Ingelheim Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020291 |
Marketing Category: | NDA |
Start Marketing Date: | 19970601 |
Package NDC: | 0597-0013-14 |
Package Description: | 1 CANISTER in 1 CARTON (0597-0013-14) > 200 AEROSOL, METERED in 1 CANISTER |
NDC Code | 0597-0013-14 |
Proprietary Name | Combivent |
Package Description | 1 CANISTER in 1 CARTON (0597-0013-14) > 200 AEROSOL, METERED in 1 CANISTER |
Product NDC | 0597-0013 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | ipratropium bromide and albuterol sulfate |
Dosage Form Name | AEROSOL, METERED |
Route Name | RESPIRATORY (INHALATION) |
Start Marketing Date | 19970601 |
Marketing Category Name | NDA |
Labeler Name | Boehringer Ingelheim Pharmaceuticals, Inc. |
Substance Name | ALBUTEROL SULFATE; IPRATROPIUM BROMIDE |
Strength Number | 103; 18 |
Strength Unit | ug/1; ug/1 |
Pharmaceutical Classes | Adrenergic beta2-Agonists [MoA],beta2-Adrenergic Agonist [EPC],Anticholinergic [EPC],Cholinergic Antagonists [MoA] |